查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
肿瘤学精密医疗的全球市场 - 产业规模，占有率，趋势，机会，预测:各生态系统，各用途，各地区(2017年～2027年)
市场调查报告书
商品编码
1152251

肿瘤学精密医疗的全球市场 - 产业规模，占有率，趋势，机会，预测:各生态系统，各用途，各地区(2017年～2027年)

Oncology Precision Medicine Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2017-2027 By Ecosystem, Precision Diagnostics, Precision Therapeutics, Applied Sciences, Hematological Malignancies, & Region
出版日期: | 出版商: TechSci Research | 英文 111 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球肿瘤学精密医疗的市场规模，预计在预测期间内的2023年～2027年以惊人的年复合成长率成长。

由于癌症盛行率增加和临床试验的治疗对象扩大，肿瘤学精密医疗的需求高涨，推动市场成长。还有老年人口的慢性疾病的风险增加牵引市场成长，预期标靶化遗传基因疗法的利用扩大促进市场成长。

本报告提供全球肿瘤学精密医疗市场相关调查分析，各市场区隔、各地区的市场规模、占有率预测，市场动态，企业简介等系统性资讯。

目录

第1章 产品概要

第2章 调查手法

第3章 摘要整理

第4章 COVID-19对全球肿瘤学精密医疗市场的影响

第5章 VOC(客户的迴响)

  • 肿瘤学精密医疗的关注
  • 癌症盛行率:各性别
  • 癌症盛行率:各年龄层
  • 癌症盛行率:各地区
  • 肿瘤学使用精密医疗的优点

第6章 临床试验分析

第7章 专利分析

第8章 全球肿瘤学精密医疗市场展望

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各生态系统(精密诊断，精密治疗，应用科学，数位健康，资讯技术)
    • 各用途(固态肿瘤和骨髓恶性肿瘤)
    • 各地区
    • 各企业(2021年)
  • 产品市场地图

第9章 北美的肿瘤学精密医疗市场展望

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各生态系统
    • 各用途
    • 各国
  • 北美:各国分析
    • 美国
    • 墨西哥
    • 加拿大

第10章 欧洲的肿瘤学精密医疗市场展望

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各生态系统
    • 各用途
    • 各国
  • 欧洲:各国分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第11章 亚太地区的肿瘤学精密医疗市场展望

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各生态系统
    • 各用途
    • 各国
  • 亚太地区:各国分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第12章 南美的肿瘤学精密医疗市场展望

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各生态系统
    • 各用途
    • 各国
  • 南美:各国分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第13章 中东、非洲的肿瘤学精密医疗市场展望

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各生态系统
    • 各用途
    • 各国
  • MEA:各国分析
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国

第14章 市场动态

  • 促进因素
  • 课题

第15章 市场趋势与开发

第16章 SWOT分析:全球肿瘤学精密医疗市场

第17章 竞争情形

  • Novartis AG
  • F. Hoffmann-La Roche AG
  • Merck & Co., Inc.
  • Danaher Corporation
  • Abbott Laboratories, Inc.
  • Quest Diagnostics Inc
  • Eurofins Genomics LLC
  • Laboratory Corporation of America Holdings
  • Thermos Fischer Scientific, Inc.
  • bioMerieux SA

第18章 策略性建议

简介目录
Product Code: 10709

The global oncology precision medicine market is expected to grow at an impressive CAGR in the forecast period, 2023-2027. Precision medicine represent the medical approach for the prevention of disease and diagnosis which is based on genetic, environmental, and behavioural variability. It helps in illnesses susceptibility prediction, diseases diagnosis, and progression, as well as medicine prescription. It assists in taking healthcare related decisions, improving quality care, and declining inefficiencies due to the trial-and-error is also augmenting the market growth. Precision medicine is widely utilized to diagnose the chromosomal abnormalities in the foetus and cancer and works for therapy for chronic diseases. The escalating demand of oncology precision medicine methods owing to the growing prevalence of cancer and the expanding number of treatment candidates in clinical trials are fueling the growth of the market.

Increasing Risk of Chronic Diseases in Geriatric Population Drives the Market Growth

Most cancer diagnoses occur in adults over the age of 65 years which demands the accurate treatment plan for this age group. Several oncologists use recommended and available geriatric assessments to help in evaluating older patients and guide their cancer treatment planning. The concept of precision medicine extends beyond tumour-specific markers to incorporate host factors that are assessed as part of a routine geriatric assessment. Oncologists are always careful to stage the cancer in creating cancer treatment plans by giving the importance of staging the aging to ensure that cancer treatments are personalized to as per the patient condition. Assessing the health status of older adults is as important and essential to optimizing treatment as assessing tumour biology and should be included alongside other precision medicine initiatives. I applaud the authors on a well-written and insightful article on implementing geriatric assessment and encourage oncology providers to use geriatric assessments in the routine care of their older patients and to apply this knowledge to individualize their care of this growing and vulnerable population.

Rise in Use of Targeted Gene Therapy is Expected to Propel the Market Growth

Gene therapy considered as one of the most lucrative markets for precision medicine organizations. Genome sequencing is an unavoidable stage of gene therapy, the extensive investments that are being made in this field drives the growth of the precision medicine market. The increase in number of cancers is escalating the demand for gene therapy as an effective personalized treatment choice across the globe. The significant growth in the number of patients necessitates gene therapy as a potential treatment approach addressing the increasing global burden of the disease. With this, the expanding adoption of emerging genomic technologies, including NGS and high-density microarray, along with the several government initiatives is propelling the market growth.

Market Segmentation

The global oncology precision medicine market is segmented into ecosystem, application, and regional distribution. Based on the ecosystem, the market is divided into precision diagnostics, precision therapeutics, applied sciences, digital health, and information technology. Based on the precision diagnostics, the market is bifurcated into molecular diagnostics and medical imaging. Based on the precision therapeutics, the market is divided into clinical trials, cell therapy, drug discovery & research, gene therapy. Based on the applied sciences, the market is divided into genomics, pharmacogenomics, others. Based on the digital health, and information technology, the market is divided into clinical decision support systems (CDSS), big data analytics, genomics informatics, in-silico informatics, others. Based on application, the market is segmented into insect scouting, crop disease scouting, weed scouting, others. Based on application, the market is bifurcated into solid tumor and hematological malignancies. Based on solid tumor, the market is segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, others. Based on hematological malignancies, the market is divided into hodgkin lymphoma, non-hodgkin lymphoma, leukemia, others. The market analysis also studies the regional segmentation, divided among North American region, Asia-Pacific region, European region, South American region, and Middle East & African region.

Market Players

Novartis AG, F. Hoffmann-La Roche AG, Merck & Co., Inc., Danaher Corporation, Abbott Laboratories, Inc., Quest Diagnostics Inc, Eurofins Genomics LLC, Laboratory Corporation of America Holdings, Thermos Fischer Scientific, Inc., bioMerieux SA are the leading market players contributing the growth of the global oncology precision medicine market.

Report Scope:

In this report, global oncology precision medicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Oncology Precision Medicine Market, By Ecosystem:

  • Precision Diagnostics
  • Precision Therapeutics
  • Applied Sciences
  • Digital Health
  • Information Technology

Oncology Precision Medicine Market, By Precision Diagnostics:

  • Molecular Diagnostics
  • Medical Imaging

Oncology Precision Medicine Market, By Precision Therapeutics:

  • Clinical Trials
  • Cell Therapy
  • Drug Discovery & Research
  • Gene Therapy

Oncology Precision Medicine Market, By Applied Sciences:

  • Genomics
  • Pharmacogenomics
  • Others

Oncology Precision Medicine Digital Health, and Information Technology:

  • Clinical Decision Support Systems (CDSS)
  • Big Data Analytics
  • Genomics Informatics
  • In-Silico Informatics
  • Others

Oncology Precision Medicine Market, By Application:

  • Solid Tumor
  • Hematological Malignancies

Oncology Precision Medicine Market, By Solid Tumor:

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Others

Oncology Precision Medicine Market, By Hematological Malignancies:

  • Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma
  • Leukemia
  • Others

Oncology Precision Medicine Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Singapore
    • Malaysia
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Poland
    • Denmark
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Peru
    • Chile
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Iraq
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global oncology precision medicine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Oncology Precision Medicine Market

5. Voice of Customer

  • 5.1. Oncology Precision Medicine Awareness
  • 5.2. Cancer Prevalence, By Gender
  • 5.3. Cancer Prevalence, By Age Group
  • 5.4. Cancer Prevalence, Region
  • 5.5. Benefits of Using Precision Medicine in Oncology

6. Clinical Trial Analysis

7. Patent Analysis

8. Global Oncology Precision Medicine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Ecosystem (Precision Diagnostics, Precision Therapeutics, Applied Sciences, Digital Health, and Information Technology)
      • 8.2.1.1. Precision Diagnostics (Molecular Diagnostics v/s Medical Imaging)
      • 8.2.1.2. Precision Therapeutics (Clinical Trials, Cell Therapy, Drug Discovery & Research, Gene Therapy)
      • 8.2.1.3. Applied Sciences (Genomics, Pharmacogenomics, Others)
      • 8.2.1.4. Digital Health, and Information Technology (Clinical Decision Support Systems (CDSS), Big Data Analytics, Genomics Informatics, In-Silico Informatics, Others)
    • 8.2.2. By Application (Solid Tumor v/s Hematological Malignancies)
      • 8.2.2.1. Solid Tumor (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
      • 8.2.2.2. Hematological Malignancies (Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Leukemia, Others)
    • 8.2.3. By Region
    • 8.2.4. By Company (2021)
  • 8.3. Product Market Map

9. North America Oncology Precision Medicine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Ecosystem (Precision Diagnostics, Precision Therapeutics, Applied Sciences, Digital Health, and Information Technology)
      • 9.2.1.1. Precision Diagnostics (Molecular Diagnostics v/s Medical Imaging)
      • 9.2.1.2. Precision Therapeutics (Clinical Trials, Cell Therapy, Drug Discovery & Research, Gene Therapy)
      • 9.2.1.3. Applied Sciences (Genomics, Pharmacogenomics, Others)
      • 9.2.1.4. Digital Health, and Information Technology (Clinical Decision Support Systems (CDSS), Big Data Analytics, Genomics Informatics, In-Silico Informatics, Others)
    • 9.2.2. By Application (Solid Tumor v/s Hematological Malignancies)
      • 9.2.2.1. Solid Tumor (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
      • 9.2.2.2. Hematological Malignancies (Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Leukemia, Others)
    • 9.2.3. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Oncology Precision Medicine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Ecosystem
        • 9.3.1.2.2. By Application
    • 9.3.2. Mexico Oncology Precision Medicine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Ecosystem
        • 9.3.2.2.2. By Application
    • 9.3.3. Canada Oncology Precision Medicine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Ecosystem
        • 9.3.3.2.2. By Application

10. Europe Oncology Precision Medicine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Ecosystem (Precision Diagnostics, Precision Therapeutics, Applied Sciences, Digital Health, and Information Technology)
      • 10.2.1.1. Precision Diagnostics (Molecular Diagnostics v/s Medical Imaging)
      • 10.2.1.2. Precision Therapeutics (Clinical Trials, Cell Therapy, Drug Discovery & Research, Gene Therapy)
      • 10.2.1.3. Applied Sciences (Genomics, Pharmacogenomics, Others)
      • 10.2.1.4. Digital Health, and Information Technology (Clinical Decision Support Systems (CDSS), Big Data Analytics, Genomics Informatics, In-Silico Informatics, Others)
    • 10.2.2. By Application (Solid Tumor v/s Hematological Malignancies)
      • 10.2.2.1. Solid Tumor (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
      • 10.2.2.2. Hematological Malignancies (Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Leukemia, Others)
    • 10.2.3. By Country
  • 10.3. Europe: Country Analysis
    • 10.3.1. France Oncology Precision Medicine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Ecosystem
        • 10.3.1.2.2. By Application
    • 10.3.2. Germany Oncology Precision Medicine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Ecosystem
        • 10.3.2.2.2. By Application
    • 10.3.3. United Kingdom Oncology Precision Medicine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Ecosystem
        • 10.3.3.2.2. By Application
    • 10.3.4. Italy Oncology Precision Medicine Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Ecosystem
        • 10.3.4.2.2. By Application
    • 10.3.5. Spain Oncology Precision Medicine Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Ecosystem
        • 10.3.5.2.2. By Application

11. Asia-Pacific Oncology Precision Medicine Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Ecosystem (Precision Diagnostics, Precision Therapeutics, Applied Sciences, Digital Health, and Information Technology)
      • 11.2.1.1. Precision Diagnostics (Molecular Diagnostics v/s Medical Imaging)
      • 11.2.1.2. Precision Therapeutics (Clinical Trials, Cell Therapy, Drug Discovery & Research, Gene Therapy)
      • 11.2.1.3. Applied Sciences (Genomics, Pharmacogenomics, Others)
      • 11.2.1.4. Digital Health, and Information Technology (Clinical Decision Support Systems (CDSS), Big Data Analytics, Genomics Informatics, In-Silico Informatics, Others)
    • 11.2.2. By Application (Solid Tumor v/s Hematological Malignancies)
      • 11.2.2.1. Solid Tumor (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
      • 11.2.2.2. Hematological Malignancies (Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Leukemia, Others)
    • 11.2.3. By Country
  • 11.3. Asia-Pacific: Country Analysis
    • 11.3.1. China Oncology Precision Medicine Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Ecosystem
        • 11.3.1.2.2. By Application
    • 11.3.2. India Oncology Precision Medicine Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Ecosystem
        • 11.3.2.2.2. By Application
    • 11.3.3. South Korea Oncology Precision Medicine Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Ecosystem
        • 11.3.3.2.2. By Application
    • 11.3.4. Japan Oncology Precision Medicine Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Ecosystem
        • 11.3.4.2.2. By Application
    • 11.3.5. Australia Oncology Precision Medicine Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Ecosystem
        • 11.3.5.2.2. By Application

12. South America Oncology Precision Medicine Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Ecosystem (Precision Diagnostics, Precision Therapeutics, Applied Sciences, Digital Health, and Information Technology)
      • 12.2.1.1. Precision Diagnostics (Molecular Diagnostics v/s Medical Imaging)
      • 12.2.1.2. Precision Therapeutics (Clinical Trials, Cell Therapy, Drug Discovery & Research, Gene Therapy)
      • 12.2.1.3. Applied Sciences (Genomics, Pharmacogenomics, Others)
      • 12.2.1.4. Digital Health, and Information Technology (Clinical Decision Support Systems (CDSS), Big Data Analytics, Genomics Informatics, In-Silico Informatics, Others)
    • 12.2.2. By Application (Solid Tumor v/s Hematological Malignancies)
      • 12.2.2.1. Solid Tumor (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
      • 12.2.2.2. Hematological Malignancies (Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Leukemia, Others)
    • 12.2.3. By Country
  • 12.3. South America: Country Analysis
    • 12.3.1. Brazil Oncology Precision Medicine Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Ecosystem
        • 12.3.1.2.2. By Application
    • 12.3.2. Argentina Oncology Precision Medicine Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Ecosystem
        • 12.3.2.2.2. By Application
    • 12.3.3. Colombia Oncology Precision Medicine Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Ecosystem
        • 12.3.3.2.2. By Application

13. Middle East and Africa Oncology Precision Medicine Market Outlook

  • 13.1. Market Size & Forecast
    • 13.1.1. By Value
  • 13.2. Market Share & Forecast
    • 13.2.1. By Ecosystem (Precision Diagnostics, Precision Therapeutics, Applied Sciences, Digital Health, and Information Technology)
      • 13.2.1.1. Precision Diagnostics (Molecular Diagnostics v/s Medical Imaging)
      • 13.2.1.2. Precision Therapeutics (Clinical Trials, Cell Therapy, Drug Discovery & Research, Gene Therapy)
      • 13.2.1.3. Applied Sciences (Genomics, Pharmacogenomics, Others)
      • 13.2.1.4. Digital Health, and Information Technology (Clinical Decision Support Systems (CDSS), Big Data Analytics, Genomics Informatics, In-Silico Informatics, Others)
    • 13.2.2. By Application (Solid Tumor v/s Hematological Malignancies)
      • 13.2.2.1. Solid Tumor (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others)
      • 13.2.2.2. Hematological Malignancies (Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Leukemia, Others)
    • 13.2.3. By Country
  • 13.3. MEA: Country Analysis
    • 13.3.1. South Africa Oncology Precision Medicine Market Outlook
      • 13.3.1.1. Market Size & Forecast
        • 13.3.1.1.1. By Value
      • 13.3.1.2. Market Share & Forecast
        • 13.3.1.2.1. By Ecosystem
        • 13.3.1.2.2. By Application
    • 13.3.2. Saudi Arabia Oncology Precision Medicine Market Outlook
      • 13.3.2.1. Market Size & Forecast
        • 13.3.2.1.1. By Value
      • 13.3.2.2. Market Share & Forecast
        • 13.3.2.2.1. By Ecosystem
        • 13.3.2.2.2. By Application
    • 13.3.3. UAE Oncology Precision Medicine Market Outlook
      • 13.3.3.1. Market Size & Forecast
        • 13.3.3.1.1. By Value
      • 13.3.3.2. Market Share & Forecast
        • 13.3.3.2.1. By Ecosystem
        • 13.3.3.2.2. By Application

14. Market Dynamics

  • 14.1. Drivers
  • 14.2. Challenges

15. Market Trends & Developments

16. SWOT Analysis: Global Oncology Precision Medicine Market

17. Competitive Landscape (Inclusive of SWOT Analysis of Players Profiled)

  • 17.1. Novartis AG
  • 17.2. F. Hoffmann-La Roche AG
  • 17.3. Merck & Co., Inc.
  • 17.4. Danaher Corporation
  • 17.5. Abbott Laboratories, Inc.
  • 17.6. Quest Diagnostics Inc
  • 17.7. Eurofins Genomics LLC
  • 17.8. Laboratory Corporation of America Holdings
  • 17.9. Thermos Fischer Scientific, Inc.
  • 17.10. bioMerieux SA

18. Strategic Recommendations